cp wire

CP Wire Articles

Tricida Announces Positive Ph III Results for First in Class Drug for Chronic Kidney Disease Related Metabolic Acidosis
  • TRC101 met both primary and secondary endpoints
  • Partients reported improved quality of life scores
  • Approximately 3 million patients in the US alone are at risk for CKD... read more
Tue, 06/5/18 - 09:24 am
EATRIS Announces Novel Public-Private Collaboration for Imaging Method Development in Inflammatory Diseases

International multi-site collaboration hub will implement new clinical imaging tools and deliver several projects per year... read more

Mon, 06/4/18 - 11:15 am
More Good News For Keytruda - Shows Promising Results in Patients with Advanced Small Cell Lung Cancer
  • Keytruda was studied as monotherapy
  • Overall response rate of 18.7%
  • In patients whose tumors expressed PD-L1 overall response rate was 35.7%

Merck (NYSE: MRK),... read more

Mon, 06/4/18 - 09:12 am
Encorafenib and Binimetinib Combination Results Show Improved Survival in Braf-Mutant Advanced Melanoma Patient
  • Median overall survival for combination 33.6 months vs 16.9 for control
  • Two year overall survival was 58%
  • Results selected for “Best of ASCO” program


Pierre... read more

Mon, 06/4/18 - 08:54 am
Pfizer Receives Good News for Trazimera (trastuzumab) Biosimilar

Pfizer Inc. (NYSE:PFE) announced on 6/1/2018 the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending marketing... read more

Fri, 06/1/18 - 09:56 am

Pages